Attending MedCity News INVEST Digital Health in September? Don't miss Brenda Schmidt, Head of Strategic Growth and Innovation at Redesign Health, moderating a panel discussion on the merits and challenges of healthcare startups focused on employers. https://lnkd.in/guXYdDmw
Redesign Health’s Post
More Relevant Posts
-
plea to Founders & Investors - do not limit your initiative to one region alone, try to open up the global skies (as patient is patient) in finding right ROI (monetary) plea to Providers- when patients are getting enormous benefits, paving the path for real transformation in their lives - What makes you to curb Digital Health Tech? Bio 9 Ventures
Healthcare executives are investing in digital health tech without seeing an ROI
mobihealthnews.com
To view or add a comment, sign in
-
🚀 Exciting news! The PitchBook Q4 2023 Digital Health Report is now live on our platform and was featured in this morning's newsletter. This insightful report delves into virtual SUD treatment, digital twins, and highlights companies like Thirty Madison and TytoCare. A huge thank you to our dedicated team for their contributions: Aaron DeGagne, CFA, Collin Anderson, Wilkins Swiger, Jenna O'Malley Ajaykumar, and others! Here are some key takeaways: 🏥 Q4 saw modest activity in the digital health sector, with notable VC funding for Healthtech unicorns Forward and Headway. 📊 Digital health funding has stabilized, with investors focusing on higher-quality startups over high-risk bets. 📈 The aggregate valuation of digital health unicorns has surged past $95 billion, hinting at potential IPOs in the near future. 🎧 Primary telehealth, digital pharmacies, and teletherapy emerged as top categories for VC funding in 2023. 💻 Virtual SUD treatment market size exceeds $10 billion, presenting significant growth opportunities, particularly for payer-covered platforms. #DigitalHealth #HealthTech #Innovation #HealthcareIndustry
Q4 2023 Digital Health Report | PitchBook
pitchbook.com
To view or add a comment, sign in
-
We’re proud to be on the list — and in such good company! We are excited to announce that Season Health has been featured on this year’s Digital Health 100. This list, published by Digital Health New York, celebrates the most innovative and exciting startups with presence in the NY healthcare ecosystem. See the full #DH100 list, just published today, and read more about the trends impacting the industry in the 2024 New York Healthcare Innovation Report: https://lnkd.in/gz8zCmSZ #DHNY #healthtech #foodasmedicine
Reports — DHNY
dhny.co
To view or add a comment, sign in
-
In the Q1 2024 New York Healthcare Innovation Report, I spoke with Bunny Ellerin of Digital Health New York about raising capital in 2024, the importance product-market fit, team, and a clear path to profitability. Download the full report for a overview of the latest trends, funding activity and more: https://lnkd.in/eZ56ibiU
Reports — DHNY
dhny.co
To view or add a comment, sign in
-
🌐 Embracing the healthcare ecosystem: Insights from Reuters Pharma Digital Health 2023 In the realm of digital health, our journey is not a solitary trek, it is a collective odyssey through a complex ecosystem. Reflecting on the recent Reuters Events Pharma Digital Health event in London, we at DayOne are excited to share selected highlights and takeaways. 👉 Cécile Tardy-Srinivasan, leading our DayOne Health 4.0 accelerator, contributed to the panel discussion around “Aligning digital health investments with true patient needs”. She highlighted the critical need for an ecosystem and partnerships-driven approach to digital health innovation, as well as the patience needed to build these successfully. At DayOne, we champion moving beyond scattered pilots and relentlessly build bridges among digital health startups and #biopharma companies, among other #healthcare stakeholders. Cecile emphasized the importance of recalibrating time scales and integrating digital health solutions into pharmaceutical developments for a sustainable relevance. Despite past hurdles, the digital health field brims with opportunities. Pharma companies now harness technology along their full value chain, starting right in R&D. This evolution underscores a patient-centric, ecosystem-focused approach, aligning with various stakeholders' interests, including physicians and payers. To seize these opportunities, the biopharma industry must learn from past experiences: selective development, evidence-based focus, consideration of diverse markets’ needs, fostering cross-functional teams and cross-sectorial talents. Utilizing new metrics, such as quality of life improvements and real-world evidence (including people’s own devices), is crucial for success. In conclusion, the digital health landscape invites a collaborative, ecosystem-oriented approach. DayOne is committed to creating solutions that genuinely meet patient needs and enhance healthcare outcomes through partnerships with health tech startups, patient organizations, healthcare practitioners, payers, tech and healthcare companies. #DigitalTransformation #DayOne #InnovateInBasel #Health4.0 #ShapingtheFutureofHealth #REdigitalEU
To view or add a comment, sign in
-
The future of public health is set to become increasingly digital, with technological advancements enabling healthcare players to provide more targeted and effective interventions to patients worldwide. Alongside growth of adoption, there has also been an acceleration in the growth of digital health start-ups and the venture investment dollars that follow. Our founder, Shameem C Hameed, recently discussed the accelerated investment in the digital health sector, the continued collapse of multiple high growth businesses and why overinvestment in health tech may actually be contributing to its downfall. Click the link below to read the article in full on pharmaphorum. 👇🏻 https://lnkd.in/eTE94yKE #digitalhealth #healthtech #businessgrowth #businesssuccess #pharma #healthcaretechnology #blueBriX
How over-investment is killing digital health companies
pharmaphorum.com
To view or add a comment, sign in
-
Digital & Med-Tech lead (Community & Primary care) @ NHS England. Skilled at making sense of "digital" in the NHS. All opinions are my own (or respectfully borrowed from people who inspire me).
👏 this is good advice and resonates with my experience of implementing digital health tech into clinical pathways.
Pitching HealthTech to large health systems like the NHS can be intimidating. 😊 But it does not have to be. Sara Nelson, a seasoned leader in the digital health space and current programme director of the prestigious DigitalHealth.London accelerator - have received many pitches throughout her career. Together with Dr Annabelle Painter, she has delivered a masterclass for healthtech #founders on how to pitch ideas and products to the NHS. (Thank you to both for your support into the production of this carousel!) 𝐈𝐧 𝐭𝐡𝐢𝐬 𝐜𝐚𝐫𝐨𝐮𝐬𝐞𝐥, 𝐰𝐞 𝐜𝐨𝐯𝐞𝐫: 🤵 Who should you pitch to (in the NHS)? 🙋♀️ How should you pitch? ✈ Best Practices for Pilot Studies. 🤝 Effective Follow up. I am incredibly excited to share this with all of you as I felt that this will be incredibly helpful to many of the founders we work with at Adopt-A-Doc! 👇 Please have a read of it and let us know what you think! ♻ Do repost this if you found it helpful! Leena Sankla FFPH, FRSPH | Estia Ryan | Kishore Sankla | Wesley S | Suman Bhaskaran | Vikram Chowdary Parimi | Daniel Carroll
To view or add a comment, sign in
-
CEO, General Manager | Creating and scaling global businesses based on innovations to improve patient outcomes | Startup, Scale-Up, Business Unit | Artificial Intelligence (AI), MedTech, Digital Health, DTx, Radiology
💥 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗶𝗻 𝗤𝟭 𝟮𝟬𝟮𝟰 𝘀𝗵𝗼𝘄𝗰𝗮𝘀𝗲𝗱 𝗮 𝘀𝗵𝗶𝗳𝘁 𝘁𝗼𝘄𝗮𝗿𝗱𝘀 𝗰𝗿𝗲𝗮𝘁𝗶𝘃𝗲 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗻𝗴 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝘀 Digital health funding in Q1 2024 showcased a shift towards creative financing measures, with $𝟮.𝟳𝗕 𝗮𝗰𝗿𝗼𝘀𝘀 𝟭𝟯𝟯 𝗱𝗲𝗮𝗹𝘀, marking a smaller yet active funding landscape. Notably, AI-driven investments surged, constituting 40% of the total funding, indicating a 𝗴𝗿𝗼𝘄𝗶𝗻𝗴 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 #𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 like clinician scribe software and precision health platforms. Moreover, there's a renewed emphasis on outcomes reporting, with 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝘀𝗲𝗲𝗸𝗶𝗻𝗴 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲-𝗯𝗮𝘀𝗲𝗱 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗳𝗿𝗼𝗺 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀. Creative deal structuring remains prevalent, with startups exploring innovative ways to secure capital, while the public markets witness a recalibration in the digitally health sector's makeup due to delistings. As expectations reset for both private and public players, the pressure intensifies to demonstrate strong outcomes and validate paths forward. 🤔 𝑯𝒐𝒘 𝒘𝒊𝒍𝒍 𝒅𝒊𝒈𝒊𝒕𝒂𝒍 𝒉𝒆𝒂𝒍𝒕𝒉 𝒄𝒐𝒎𝒑𝒂𝒏𝒊𝒆𝒔 𝒏𝒂𝒗𝒊𝒈𝒂𝒕𝒆 𝒕𝒉𝒆𝒔𝒆 𝒔𝒉𝒊𝒇𝒕𝒊𝒏𝒈 𝒑𝒂𝒓𝒂𝒅𝒊𝒈𝒎𝒔, 𝒃𝒂𝒍𝒂𝒏𝒄𝒊𝒏𝒈 𝒕𝒉𝒆 𝒏𝒆𝒆𝒅 𝒇𝒐𝒓 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒗𝒆 𝒔𝒐𝒍𝒖𝒕𝒊𝒐𝒏𝒔 𝒘𝒊𝒕𝒉 𝒕𝒉𝒆 𝒅𝒆𝒎𝒂𝒏𝒅 𝒇𝒐𝒓 𝒕𝒂𝒏𝒈𝒊𝒃𝒍𝒆 𝒐𝒖𝒕𝒄𝒐𝒎𝒆𝒔 𝒂𝒏𝒅 𝒔𝒖𝒔𝒕𝒂𝒊𝒏𝒂𝒃𝒍𝒆 𝒈𝒓𝒐𝒘𝒕𝒉? #artificialintelligence
To view or add a comment, sign in
-
#HealthTech Transformation: Twin Health Raises the Stakes with $50M Funding Twin Health's remarkable $50M funding round headed by Temasek is a game-changer in personalized healthcare. Boasting participants like Sofina and ICONIQ Capital Growth, this investment propels their Whole Body Twin Technology to the forefront of managing metabolic diseases. Why This Matters: 🧬 The Whole Body Digital Twin is trailblazing patient-specific healthcare through AI, setting the stage to overturn the status quo in disease prevention and reversal, notably Type 2 diabetes. 🧬 With industry giants such as Tata Consultancy Services predicting digital twins to be ubiquitous in healthcare by 2026, the industry is sprinting toward a technological renaissance. Strategic Insights: $ The heavy hitting confidence of investors in digital health underscores an acute market shift toward AI-powered, personalized healthcare models. $ With the escalation of digital twins, the industry can expect a reduction in traditional system burdens and an uptick in health outcomes and payer satisfaction. $ The anticipation for market disruption is ripe—innovators and providers should pivot to integrate these evolutions and drive competitive service delivery models. Investment Implications: ♟️ As Twin Health exemplifies, investing in companies that prioritize individualized solutions promises to redefine and spur growth in the healthcare sector. ♟️ The ascendancy of AI in diagnostic and treatment precision invites industry stakeholders to leverage these tools for enhanced, futuristic healthcare delivery. ♟️ Agility in adopting healthcare advancements will not just be a competitive edge but a survival imperative in the evolving marketplace. We are witnessing a monumental stride in health tech innovation, and Twin Health's triumphant funding is just the beginning. For those looking to pioneer alongside cutting-edge healthcare disruptions, the time is now. Stay at the vanguard of industry innovation with Market Unwinded – Your lens into the future of health tech investment. Read More: https://lnkd.in/g89NTcEF #DigitalHealth #InvestmentInsight #AIHealthcare #MetabolicHealth #TwinHealthInvestment #FutureIsNow Navigate Tomorrow’s Healthcare, Today: Embrace the Digital Revolution with #MarketUnwinded.
Revolutionizing Healthcare: Twin Health's Digital Twin Innovation Attracts Major Investment
marketunwinded.com
To view or add a comment, sign in
-
In our latest premium research, the team delved into the importance of Big Tech in Digital Health innovation. Our analysis revealed that while Big Tech’s role in Digital Health innovation is complementary, their substantial resources and technological prowess are crucial in forging impactful partnerships. Big Tech leverages its tech capabilities to enhance healthcare delivery, albeit with careful consideration of patient-centric values and regulatory requirements. Startups, academic institutions, and healthcare organizations remain at the forefront, driving the unique advancements needed in this specialized field. However, there have been significant trends and developments over the past five years. Partnerships between tech companies and Digital Health ventures have grown at an impressive CAGR of 32%, surpassing the 29% growth rate of non-tech corporate collaborations. As of May 2024, Tech has overtaken Biopharma, claiming a 10% share of partnerships with Digital Health initiatives. Follow Galen Growth | Insights You Can Trust and subscribe to HealthTech Alpha #DigitalHealth #HealthTech #BigTech #Innovation #Healthcare #TechPartnerships #HealthTechResearch #HealthcareInnovation #HealthTechTrends https://lnkd.in/gPM5G9d6
Is Big Tech Important to Digital Health Innovation?
galengrowth.com
To view or add a comment, sign in
46,333 followers